HealthBaby Biotech

What HealthBaby Biotech does

HealthBaby Biotech (Hong Kong) Co., Ltd is a privately held cord blood and umbilical cord lining stem cell banking company founded in 2006 and headquartered at the Hong Kong Science and Technology Park in Shatin. It operates a near 10,000 sq. ft. laboratory facility equipped with the BioArchive automated liquid nitrogen storage system, the AXP automated processing system, and the DATAssure laboratory monitoring system, holding accreditations from AABB, CAP, FACT, the Medical Laboratory Technologists Board, and ISBT 128.

The company sells multi-year (18-year) storage contracts for hematopoietic stem cells from cord blood, as well as mesenchymal stem cell (MSC) and epithelial stem cell (EpSC) storage from umbilical cord lining under its CordBasic and CordPlus plans, with bundled offerings including up to HK$300,000 of transplant care insurance and professional compensation coverage. Its go-to-market is sales-led, combining dedicated cord blood consultants, an obstetrics and gynecology doctor referral network across Hong Kong private hospitals, prenatal seminars, and a presence at the annual Hong Kong Baby Products Expo, supported by WhatsApp, WeChat, and XiaoHongShu digital channels. A regional office in Macau extends service to expectant parents delivering there.

HealthBaby derives recurring subscription revenue from 18-year storage contracts with renewal options, plus cross-sell of cord lining services, and commands over 90% market share among Hong Kong cord blood banks per Ipsos surveys covering 2009-2025. The company has recorded over 30,000 successful cord blood transplant cases (5,097 in 2024 alone) and over 65,000 cord lining or tissue transplant cases, and operates an affiliated international cord blood searching network that provides sample transfer guarantees.

Name

HealthBaby Biotech

Legal name

HealthBaby Biotech (Hong Kong) Co., Ltd

Website

https://healthbaby.hk

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

HealthBaby Biotech is a privately held Hong Kong cord blood and umbilical cord lining stem cell banking company founded in 2006, serving expectant parents in Hong Kong and Macau through 18-year storage subscriptions using BioArchive and AXP systems and commanding over 90% local market share.

Ownership category

akta.pro rank

Product category

Cord Blood Banking Services

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Health Services (8000)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)

Keywords

• Cord blood banking
• Stem cell storage
• Umbilical cord lining
• Cryopreservation services
• Regenerative medicine storage

Headquarters

HQ city

Sha Tin

HQ country

Hong Kong SAR China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Cord Blood Storage Service: Recurring subscription-based service where customers pay a one-time fee covering registration, processing, and 18 years of storage. The fee includes all charges with no additional costs during the contracted period. Customers can choose between different plans based on storage and processing systems (Platinum, Premium, Basic). Renewal fees apply after the initial 18-year period.
2. Cord Lining Storage Service: Subscription-based storage service for umbilical cord lining containing MSCs and EpSCs. Customers can choose between different forms: mesenchymal stem cells cryogenic storage or umbilical cord tissue cryogenic storage. Includes 18-year storage with renewal options.
3. Transplant Care Insurance: Up to HK$300,000 transplant care insurance coverage provided as part of the service package, covering transplantation costs and experimental treatment for the child and immediate family members.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

HealthBaby Biotech provides cryopreservation and long-term storage services for newborn cord blood hematopoietic stem cells (HSCs) and umbilical cord lining mesenchymal (MSCs) and epithelial stem cells (EpSCs) for expectant parents in Hong Kong and Macau. The company uses the BioArchive automated liquid nitrogen storage system, the AXP automated processing system, and proprietary cord lining technology to preserve stem cells for up to 18 years, with optional transplant care insurance and compensation coverage.

Product overview

HealthBaby Biotech offers a comprehensive cord blood and umbilical cord lining banking service for families. The company provides three main storage services: 18-year Cord Blood (HSCs) Storage using the BioArchive Liquid Nitrogen Storage System and AXP Processing System; CordBasic Umbilical Cord Lining Storage for mesenchymal stem cells (MSCs); and CordPlus Umbilical Cord Lining Storage for both MSCs and epithelial stem cells (EpSCs). Additional offerings include HK$300,000 Transplant Care Insurance, Full Refund Guarantee, and Professional Compensation Insurance up to HK$56,000,000. The company operates the DATAssure Laboratory Monitoring System for quality assurance. Established since 2006, HealthBaby is the largest cord blood bank in Hong Kong with laboratory facilities at Hong Kong Science Park.

Differentiator

Problem solved

Functional benefit

Products and services

• 18-year Cord Blood (HSCs) Storage

Quantifiable outcome

• Over 30,000 successful cord blood transplant cases as of December 2024
• +3 more outcomes

Named customers11 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Affiliated Public Cord Blood Bank NetworkcoreStrategic or Co-development PartnerHealthBaby maintains an affiliated network with public cord blood banks, providing clients with access to international cord blood searching network. If HealthBaby terminates operations, samples would be transferred to a client-agreed cord blood bank within the network.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Biovault Family: UK-based private cord blood and tissue storage provider; similar long-duration storage business model though primarily serving UK families.
• Cells4Life: UK private cord blood and tissue bank with similar subscription storage model; comparable offering but geographically limited to the UK/Ireland market.
• Smart Cells International: UK-focused private cord blood bank offering HSC storage under multi-year contracts; comparable service model but operates in a different geography and lacks MSC/EpSC cord lining depth.

Others

• Mesoblast: Clinical-stage cellular medicine company developing MSC-based therapies; not a direct competitor but represents the downstream regenerative medicine opportunity that HealthBaby's stored cord lining samples could ultimately supply.

Emerging players

• Auxocell Laboratories: Cord tissue-focused bank and stem cell processing company specializing in MSC and EpSC isolation from cord lining — directly comparable to HealthBaby's patented cord lining technology.
• StemCyte: International cord blood bank with operations in California, India, and Taiwan; comparable HSC storage service with public-private banking hybrids and an emerging presence across Asia.

Broad incumbents

• Cryo-Cell International: US-listed, established private cord blood bank offering similar multi-year cryopreservation services; broader geographic footprint but overlapping product economics, accreditations, and consumer sales-led model.
• CBR (Generate Life Sciences): One of the largest US private cord blood banks, operating for over 25 years and offering HSC and cord tissue storage with AABB accreditation; comparable subscription model and consumer GTM.
• ViaCord: US cord blood bank owned by PerkinElmer offering HSC and cord tissue storage; comparable subscription economics and accreditation profile though operating in a different geography.

Direct peers

• CordLife Limited: Singapore-listed cord blood banking group with operations across Asia including Hong Kong and Macau, offering nearly identical HSC and MSC/EpSC storage services — the most directly comparable peer to HealthBaby in its core geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/healthbabyhk

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthBaby Biotech